Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis
Dietrich Abeck
, Tanja Schmidt
, Heike Fesq
, Kerstin Strom
, Martin Mempel
,
Knut Brockow
,
Johannes Ring
TUM Emeriti of Excellence
Department of Dermatology and Allergology
Technical University of Munich
Research output
:
Contribution to journal
›
Article
›
peer-review
104
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Atopic Dermatitis
100%
Long-term Efficacy
100%
Phototherapy
100%
UVA1
100%
Irradiation
28%
Highly Effective
28%
Treatment Duration
14%
Therapeutic Efficacy
14%
Therapeutic Potential
14%
Therapeutic Effectiveness
14%
Observation Period
14%
Skin Condition
14%
UV Treatment
14%
In Vivo Animal Studies
14%
In Vitro Cell Culture
14%
Optimal Dose
14%
Cumulative Dose
14%
Skin Melanoma
14%
SCORAD Score
14%
Skin Carcinogenesis
14%
UVA Radiation
14%
Skin Photoaging
14%
Non-steroidal
14%
Clinical Severity
14%
Observation Interval
14%
Symptom Recurrence
14%
Severe Atopic Dermatitis
14%
Applied Dose
14%
SCORing Atopic Dermatitis (SCORAD)
14%
Phototherapeutic
14%
Medicine and Dentistry
Atopic Dermatitis
100%
Phototherapy
100%
Side Effect
40%
Combination Therapy
20%
In Vitro
20%
Recurrent Disease
20%
Skin Carcinogenesis
20%
Optimal Drug Dose
20%
Melanoma
20%
Cell Culture
20%
Photoaging
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Side Effect
40%
Cell Culture
20%
Recurrent Disease
20%
Melanoma
20%
Skin Carcinogenesis
20%
Combination Therapy
20%
Photoaging
20%
Immunology and Microbiology
Atopic Dermatitis
100%
SCORAD
40%
Cell Culture
20%
Animal Experiment
20%
Optimal Drug Dose
20%
In Vitro
20%
Pretreatment
20%